{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:36:33Z","timestamp":1793424993685,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1003000"],"award-info":[{"award-number":["2018YFC1003000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>17\u03b1-hydroxylase\/17, 20-lyase deficiency (17-OHD) is caused by the mutations of the <jats:italic>CYP17A1<\/jats:italic> gene. The classical phenotype of 17-OHD includes hypertension, hypokalemia, and abnormal sexual development, with partial 17-OHD typically less severe than the complete deficiency. Infertility is always one of the main clinical manifestations of partial 17-OHD. However, to date, the pregnancy potentials of partial 17-OHD female patients have rarely been investigated, and few live-birth cases have been reported among them. Moreover, the reproductive endocrine characteristics of partial 17-OHD female patients have not been completely clarified and the treatment skills of <jats:italic>in vitro<\/jats:italic> fertilization and embryo transfer (IVF-ET) have not been well summarized yet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two Chinese infertile female patients clinically diagnosed as partial 17-OHD were enrolled and their pedigree investigations were performed. Hormones were determined to depict the endocrine conditions of partial 17-OHD female patients. The adrenocorticotropic hormone (ACTH) stimulation test was performed to evaluate the functions of the adrenal cortex. Genotype analysis was conducted by next-generation sequencing (NGS) and Sanger sequencing was used to verify the results. IVF-ET was performed for the treatment of their infertility. Specifically, the progestin-primed ovarian stimulation (PPOS) protocol was chosen for the controlled ovarian hyperstimulation (COH) cycles, and the hormone replacement treatment (HRT) protocol was adopted for the endometrial preparation in frozen\u2013thawed embryo transfer (FET) cycles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Hormone assays revealed a reduced estradiol (E2) and testosterone (T) level, and an elevated progesterone (P4) level. The classic ACTH stimulating test evidenced a suboptimal response of cortisol to ACTH. Genotype analysis demonstrated that the proband1 carried two variants: c.1459_1467del (p.Asp487_Phe489del)<jats:sup>het<\/jats:sup> and c.995T&amp;gt;C (p.lle332Thr)<jats:sup>het<\/jats:sup>. The proband2 was found to be a homozygote with the mutation of c.1358T&amp;gt;A (p.Phe453Ser)<jats:sup>hom<\/jats:sup>. The two female patients both succeeded in pregnancy and delivery of healthy babies through IVF-ET, with the usage of PPOS, HRT, and low-dose glucocorticoids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Partial 17-OHD female patients manifested menstrual cycle disorders and infertility clinically; displayed high P4 and low E2 and T; showed sparse pubic hair in physical examinations; and revealed multiple ovarian cysts in ultrasonic visualization. Moreover, the pregnancy potentials of infertile partial 17-OHD women seemed to increase with the adoption of IVF-ET. Considering the sustained elevated P4 level, PPOS is a feasible protocol for them in COH.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.970190","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:36:06Z","timestamp":1663202166000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Reproductive endocrine characteristics and in vitro fertilization treatment of female patients with partial 17\u03b1-hydroxylase deficiency: Two pedigree investigations and a literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Shutian","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0960-0760(01)00105-4","article-title":"17-hydroxylase: An evaluation of the present view of its catalytic role in steroidogenesis","volume":"78","author":"Lieberman","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(08)70021-5","article-title":"The genetics, pathophysiology, and management of human deficiencies of P450c17","volume":"30","author":"Auchus","year":"2001","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2005.06.035","article-title":"Novel mutation of the CYP17 gene in two unrelated patients with combined 17alpha-hydroxylase\/17,20-lyase deficiency: Demonstration of absent enzyme activity by expressing the mutant CYP17 gene and by three-dimensional modeling","volume":"97","author":"Patocs","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.3535074","article-title":"Expression of bovine 17 alpha-hydroxylase cytochrome p-450 cDNA in nonsteroidogenic (COS 1) cells","volume":"234","author":"Zuber","year":"1986","journal-title":"Sci (New York NY)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ng1097-201","article-title":"The genetic and functional basis of isolated 17,20-lyase deficiency","volume":"17","author":"Geller","year":"1997","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.6029","article-title":"17\u03b1\u2212hydroxylase\/17,20\u2212lyase deficiency in congenital adrenal hyperplasia: A case report","volume":"15","author":"Xu","year":"2017","journal-title":"Mol Med Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2015.42.2.72","article-title":"A case of 17 alpha-hydroxylase deficiency","volume":"42","author":"Kim","year":"2015","journal-title":"Clin Exp Reprod Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0834","article-title":"Partial deficiency of 17\u03b1-hydroxylase\/17,20-lyase caused by a novel missense mutation in the canonical cytochrome heme-interacting motif","volume":"172","author":"Rubtsov","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/09513590.2019.1683819","article-title":"A rare enzymatic defect, true isolated 17,20-lyase deficiency leading to endocrine disorders and infertility: Case report","volume":"36","author":"Afsar","year":"2020","journal-title":"Gynecological Endocrinol Off J Int Soc Gynecological Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30101-4","article-title":"Disorders of steroid 17 alpha-hydroxylase deficiency","volume":"23","author":"Kater","year":"1994","journal-title":"Endocrinol Metab Clinics North Am"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.11.063","article-title":"Isolated 17,20-lyase (desmolase) deficiency in a 46,XX female presenting with delayed puberty","volume":"83","author":"Simsek","year":"2005","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.11.011","article-title":"Fertility in patients with genetic deficiencies of cytochrome P450c17 (CYP17A1): Combined 17-hydroxylase\/17,20-lyase deficiency and isolated 17,20-lyase deficiency","volume":"101","author":"Marsh","year":"2014","journal-title":"Fertil Steril"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021206704958","article-title":"Familial partial 17,20-desmolase and 17alpha-hydroxylase deficiency presenting as infertility","volume":"20","author":"Levran","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac029","article-title":"Phenotypic heterogeneity and fertility potential of patients with 17-Hydroxylase\/17,20-lyase deficiency","volume":"107","author":"Xu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab222","article-title":"Successful delivery in 17,20-lyase deficiency","volume":"106","author":"Blumenfeld","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a136319","article-title":"Induction of artificial endometrial cycles with oestradiol implants and injectable progesterone: Establishment of a viable pregnancy in a woman with 17-alpha-hydroxylase deficiency","volume":"10","author":"Ben-Nun","year":"1995","journal-title":"Hum Reprod"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13549","article-title":"Successful fertility outcome in a woman with 17\u03b1-hydroxylase deficiency","volume":"88","author":"Falhammar","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1393512","article-title":"Two consecutive successful live birth in woman with 17\u03b1 hydroxylase deficiency by frozen-thaw embryo transfer under hormone replacement endometrium preparation","volume":"34","author":"Kitajima","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3201","article-title":"Successful live birth in a woman with 17\u03b1-hydroxylase deficiency through IVF frozen-thawed embryo transfer","volume":"101","author":"Bianchi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03607.x","article-title":"Identification of steroid biosynthetic defects in genotype-proven heterozygous individuals for 17alpha-hydroxylase\/17,20-lyase deficiency","volume":"72","author":"Qiao","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/cen.13481","article-title":"The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization","volume":"88","author":"Jiang","year":"2018","journal-title":"Clin Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4158\/EP161610.OR","article-title":"17\u03b1-HYDROXYLASE\/17, 20-LYASE DEFICIENCY: CLINICAL AND MOLECULAR CHARACTERIZATION OF EIGHT CHINESE PATIENTS","volume":"23","author":"Wu","year":"2017","journal-title":"Endocrine Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230778","article-title":"Partial deficiency of 17\u03b1-hydroxylase: A rare cause of congenital adrenal hyperplasia","volume":"12","author":"Sousa Paredes","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/09513590802194051","article-title":"Partial 17alpha-hydroxylase\/17,20-lyase deficiency-clinical report of five Chinese 46,XX cases","volume":"24","author":"Tian","year":"2008","journal-title":"Gynecological Endocrinol Off J Int Soc Gynecological Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.77.2.8345056","article-title":"Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency","volume":"77","author":"Fardella","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(09)60342-9","article-title":"Seventeen alpha-hydroxylase deficiency","volume":"105","author":"Wong","year":"2006","journal-title":"J Formosan Med Assoc = Taiwan yi zhi"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2283","article-title":"Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase\/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene","volume":"91","author":"Yang","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.02.007","article-title":"New, recurrent, and prevalent mutations: Clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase\/17,20-lyase deficiency","volume":"150","author":"Zhang","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(02)00156-9","article-title":"A complex heterozygous mutation of His373Leu and Asp487-Ser488-Phe489 deletion in human cytochrome P450c17 causes 17alpha-hydroxylase\/17,20-lyase deficiency in three Chinese sisters","volume":"201","author":"Qiao","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2011.631625","article-title":"Phenotypic variation in a Chinese family with 46,XY and 46,XX 17\u03b1-hydroxylase deficiency","volume":"28","author":"Bee","year":"2012","journal-title":"Gynecological Endocrinol Off J Int Soc Gynecological Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000284362","article-title":"Clinical, genetic and functional characteristics of three novel CYP17A1 mutations causing combined 17alpha-hydroxylase\/17,20-lyase deficiency","volume":"73","author":"Rosa","year":"2010","journal-title":"Hormone Res Paediatrics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsp.5640220","article-title":"The molecular basis of congenital atrichia in humans and mice: mutations in the hairless gene","volume":"4","author":"Ahmad","year":"1999","journal-title":"J Invest Dermatol Symposium Proc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: A double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"BJOG"},{"key":"B38","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI(\u2020)","volume":"2020","author":"Ovarian Stimulation","year":"2020","journal-title":"Hum Reprod Open"},{"key":"B39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0960-0760(93)90125-G","article-title":"Prenatal diagnosis and treatment of 21-hydroxylase deficiency","volume":"45","author":"Forest","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1055\/a-0893-3122","article-title":"The cycle characteristics and outcomes of infertile nonclassic 21-hydroxylase deficiency patients undergoing ovarian stimulation for In vitro fertilization","volume":"51","author":"Jiang","year":"2019","journal-title":"Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones Metabolisme"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/3.2.101","article-title":"Follicular development and oocyte maturation in hypogonadotrophic women employing recombinant follicle-stimulating hormone: The role of oestradiol","volume":"3","author":"Fauser","year":"1997","journal-title":"Hum Reprod Update"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590.2019.1707798","article-title":"A rare cause of delayed puberty in two cases with 46,XX and 46,XY karyotype: 17 \u03b1-hydroxylase deficiency due to a novel variant in CYP17A1 gene","volume":"2019","author":"Unal","year":"2020","journal-title":"Gynecological Endocrinol Off J Int Soc Gynecological Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21037\/atm-20-3623","article-title":"Endometrial cavity fluid is associated with deleterious pregnancy outcomes in patients undergoing in vitro fertilization\/intracytoplasmic sperm injection: a retrospective cohort study","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.12.2610","article-title":"Endometrial cavity fluid is associated with poor ovarian response and increased cancellation rates in ART cycles","volume":"16","author":"Levi","year":"2001","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.970190\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:36:09Z","timestamp":1663202169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.970190\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":44,"alternative-id":["10.3389\/fendo.2022.970190"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.970190","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"article-number":"970190"}}